
Fluoxetine, commonly known as Prozac, is a selective serotonin reuptake inhibitor (SSRI) antidepressant. While it has been studied for its potential to enhance brain plasticity, particularly in stroke recovery, large-scale trials have shown mixed results regarding its direct impact on motor function recovery, though it can help with depression.
So for fluoxitine, it looked really promising. There was a big initiative on stem cells.
"
"Fluoxetine is discussed in the context of its potential, and ultimately limited, effectiveness in enhancing neuroplasticity for stroke recovery, contrasting it with the more promising results seen in animal models."




